Literature DB >> 16718465

Renal amino acid, fat and glucose metabolism in type 1 diabetic and non-diabetic humans: effects of acute insulin withdrawal.

N Moller1, M D Jensen, R A Rizza, J C Andrews, K S Nair.   

Abstract

AIMS/HYPOTHESIS: The aim of this study was to test the hypothesis that type 1 diabetes alters renal amino acid, glucose and fatty acid metabolism.
MATERIALS AND METHODS: We studied five C-peptide-negative, type 1 diabetic subjects during insulin replacement (glucose 5.6 mmol/l) and insulin deprivation (glucose 15.5 mmol/l) and compared them with six non-diabetic subjects. Leucine, phenylalanine, tyrosine, glucose and palmitate tracers were infused after an overnight fast and samples were obtained from the renal vein, femoral vein and femoral artery.
RESULTS: Insulin deprivation significantly increased whole-body fluxes (20-25%) of phenylalanine, tyrosine and leucine, and leucine oxidation (50%). Kidney contributed 5-10% to the whole-body leucine and phenylalanine flux. A net uptake of phenylalanine, conversion of phenylalanine to tyrosine (5 micromol/min) and net release of tyrosine (approximately 5 micromol/min) occurred across the kidney. Whole-body (three-fold) and leg (two-fold) leucine transamination increased but amino acid metabolism in the kidney did not alter with diabetes or insulin deprivation. Insulin deprivation doubled endogenous glucose production, renal glucose production was unaltered by insulin deprivation and diabetes (ranging between 100 and 140 micromol/min). Renal palmitate exchange was unaltered by insulin deprivation. CONCLUSIONS/
INTERPRETATION: In conclusion, kidney post-absorptively accounts for 5-10% of whole-body protein turnover, 15-20% of leucine transamination and 10-15% of endogenous glucose production, and actively converts phenylalanine to tyrosine. During insulin deprivation, leg becomes a major site for leucine transamination but insulin deprivation does not affect renal phenylalanine, leucine, palmitate or glucose metabolism. Despite its key metabolic role, insulin deprivation in type 1 diabetic patients does not alter many of these metabolic functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718465     DOI: 10.1007/s00125-006-0287-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: A metabolic role of the kidney.

Authors:  N Møller; S Meek; M Bigelow; J Andrews; K S Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  ON DIABETIC ACIDOSIS: A Detailed Study of Electrolyte Balances Following the Withdrawal and Reestablishment of Insulin Therapy.

Authors:  D W Atchley; R F Loeb; D W Richards; E M Benedict; M E Driscoll
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

4.  Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting.

Authors:  K Ekberg; B R Landau; A Wajngot; V Chandramouli; S Efendic; H Brunengraber; J Wahren
Journal:  Diabetes       Date:  1999-02       Impact factor: 9.461

5.  Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset.

Authors:  T A Hillier; K L Pedula
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

6.  Renal substrate exchange in human diabetes mellitus.

Authors:  J Wahren; P Felig
Journal:  Diabetes       Date:  1975-08       Impact factor: 9.461

7.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine.

Authors:  M Stumvoll; U Chintalapudi; G Perriello; S Welle; O Gutierrez; J Gerich
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Insulin regulation of renal glucose metabolism in humans.

Authors:  E Cersosimo; P Garlick; J Ferretti
Journal:  Am J Physiol       Date:  1999-01

9.  Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man.

Authors:  T Brundin; J Wahren
Journal:  Am J Physiol       Date:  1994-11

10.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients.

Authors:  K S Nair; G C Ford; K Ekberg; E Fernqvist-Forbes; J Wahren
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more
  8 in total

1.  Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis.

Authors:  Thomas S Voss; Mikkel H Vendelbo; Ulla Kampmann; Steen B Pedersen; Thomas S Nielsen; Mogens Johannsen; Mads V Svart; Niels Jessen; Niels Møller
Journal:  Diabetologia       Date:  2018-12-01       Impact factor: 10.122

2.  Effects of insulin-induced hypoglycaemia on lipolysis rate, lipid oxidation and adipose tissue signalling in human volunteers: a randomised clinical study.

Authors:  Thomas S Voss; Mikkel H Vendelbo; Ulla Kampmann; Steen B Pedersen; Thomas S Nielsen; Mogens Johannsen; Mads V Svart; Niels Jessen; Niels Møller
Journal:  Diabetologia       Date:  2016-10-12       Impact factor: 10.122

3.  Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes.

Authors:  Mads V Svart; Nikolaj Rittig; Ulla Kampmann; Thomas S Voss; Niels Møller; Niels Jessen
Journal:  Diabetologia       Date:  2017-04-07       Impact factor: 10.122

4.  The Effect of Glucagon on Protein Catabolism During Insulin Deficiency: Exchange of Amino Acids Across Skeletal Muscle and the Splanchnic Bed.

Authors:  Haleigh James; Wilson I Gonsalves; Shankarappa Manjunatha; Surendra Dasari; Ian R Lanza; Katherine A Klaus; Adrian Vella; James C Andrews; K Sreekumaran Nair
Journal:  Diabetes       Date:  2022-08-01       Impact factor: 9.337

Review 5.  Mini-review: Glucagon responses in type 1 diabetes - a matter of complexity.

Authors:  Mads Bisgaard Bengtsen; Niels Møller
Journal:  Physiol Rep       Date:  2021-08

6.  Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism.

Authors:  Kevin R Short; Brian A Irving; Ananda Basu; C Michael Johnson; K Sreekumaran Nair; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

7.  Functional impact of high protein intake on healthy elderly people.

Authors:  Stephane Walrand; Kevin R Short; Maureen L Bigelow; Andrew J Sweatt; Susan M Hutson; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-12       Impact factor: 4.310

Review 8.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.